Skip to content
Back to search results

Lower Extremity Functional Scale

Introduced by
Jill M. Binkley, Paul W. Stratford, Sheila A. Lott, Duane L. Riddle
Year
1999
Type
Patient self-report
Family
lower-extremity-functional
Font size

What does it do?

The Lower Extremity Functional Scale (LEFS) is a 20-item patient self-report instrument designed to assess functional limitations in individuals with lower extremity musculoskeletal disorders.

Developed by Binkley, Stratford, Lott, and Riddle in 1999 and published in Physical Therapy, the LEFS provides a validated, general lower-extremity outcome measure applicable across diverse pathologies (knee, ankle, hip, foot injuries and conditions), making it particularly valuable in physical therapy and rehabilitation settings.

The intuition behind the method

The LEFS was designed to create a unified outcome measure for the entire lower extremity—addressing a gap in the field where condition-specific scales existed (e.g., knee scales, ankle scales) but a generic lower-extremity instrument was lacking. The LEFS measures functional limitations across 20 common daily and instrumental activities (walking, stairs, standing, running, jumping, cutting, kneeling, squatting, shopping, household tasks) on a 0–4 Likert scale (unable to perform = 0, able to perform without difficulty = 4). The total score ranges 0–80, where higher scores indicate better function. With a well-established minimal clinically important difference (MCID) of 9 points, the LEFS is responsive to both improvement and deterioration over weeks to months, making it ideal for rehabilitation tracking.

History

The LEFS was developed by Binkley and colleagues (physical therapists and rehabilitation researchers) to address the need for a generic lower-extremity outcome measure applicable across diverse pathologies and patient populations. Prior to 1999, outcome assessment in lower-extremity rehabilitation was fragmented—condition-specific scales existed for knee and ankle but not an overarching measure of lower-extremity function. The LEFS was developed through systematic item generation (literature review and expert input), reliability and validity testing in diverse patient cohorts (ankle injury, knee injury, hip pain, surgical patients), and publication in Physical Therapy in 1999. It has since become widely adopted in physical therapy practices and research, translated into >30 languages, and extensively validated across age groups, pathologies, and settings.

When to use it

The LEFS is indicated for any patient with lower-extremity musculoskeletal dysfunction, including ankle sprains, knee injuries, hip pain, foot pathology, post-surgical rehabilitation (ACL, meniscus, ankle ligament, hip/knee arthroplasty), and chronic conditions (osteoarthritis, plantar fasciitis). It is particularly valuable in physical therapy and orthopedic rehabilitation settings where a generic, condition-independent outcome measure is needed to track functional change across heterogeneous patient populations. The LEFS is preferred over condition-specific scales (IKDC for knee, FAOS for ankle) when the primary clinical question involves overall lower-extremity function rather than a single joint. Use LEFS when rapid, generic functional assessment is needed; condition-specific scales should supplement LEFS if detailed joint-specific information is important.

Limitations and considerations

  • Generic instrument does not capture condition-specific details; for detailed knee-specific or ankle-specific outcomes, combine LEFS with disease-specific scales (IKDC, FAOS).
  • Requires reading comprehension at 6th–8th grade level; less suitable for populations with cognitive impairment or language barriers without validated translation.
  • Activities may not apply uniformly across populations (e.g., 'running' less relevant for elderly sedentary patients); interpretation should account for patient baseline activity level.
  • No subscale structure; single composite score limits ability to identify specific functional domains (e.g., is limitation from weakness, pain, balance, or fear?).

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Excellent test–retest reliability (ICC 0.88–0.96) and internal consistency (Cronbach α 0.96); robust across age groups and lower-extremity pathologies.
  • Condition-independent; applies equally well to ankle, knee, hip, foot, and multi-joint injuries; enables outcome comparison across diverse lower-extremity diagnoses.
  • Highly responsive to rehabilitation; change is measurable over 2–4 weeks; well-established MCID of 9 points provides clear meaningful change thresholds.
  • Brief (20 items, 5–10 minutes); simple 0–4 Likert scale; free, widely available in >30 languages; extensively used in physical therapy and research, enabling meta-analysis.

Applications

  • Post-injury rehabilitation tracking: monitoring functional recovery in ankle sprains, knee injuries, hip strains; serial LEFS every 2 weeks informs therapy progression and return-to-activity decisions.
  • Post-surgical rehabilitation outcomes: evaluating functional recovery following ACL reconstruction, meniscectomy, ankle ligament surgery, total knee/hip arthroplasty; LEFS sensitivity to change guides rehabilitation intensity adjustment.
  • Comparative rehabilitation trials: used as a primary outcome in randomized controlled trials comparing rehabilitation protocols, manual therapy approaches, exercise programs, or assistive device efficacy.
  • Work capacity and return-to-work assessment: LEFS scores correlate with work-related function; used to inform work-capacity evaluations and return-to-work timelines.
  • Longitudinal outcomes tracking in electronic health records: serial LEFS data enables outcome benchmarking, quality improvement initiatives, and identification of patients at risk for poor outcomes.

How it works

How it works

1

The LEFS contains 20 items addressing functional activities: walking distance (two stairs, multiple flights, level surface), stairs (up, down, single step), standing and positional changes (prolonged standing, getting in/out of car, bed, bath), lower-extremity motor tasks (running, jumping, cutting/pivoting, kneeling, squatting, hopping), and instrumental activities (shopping, household chores, light recreational activities). Each item is rated on a 0–4 scale: 0 = unable to perform activity, 1 = quite a bit of difficulty, 2 = moderate difficulty, 3 = a little difficulty, 4 = no difficulty. The patient completes the form independently in 5–10 minutes, self-selecting the best response for each activity. No equipment or clinician involvement is required.

2

Each of the 20 items is scored 0–4. The total raw score is the sum of all 20 items, ranging 0–80. No reverse scoring or subscale computation is needed; a single composite score is generated. Higher scores indicate better lower-extremity function. Score interpretation: 70–80 = minimal functional limitation; 50–70 = mild-to-moderate limitation; 30–50 = moderate-to-severe limitation; <30 = severe functional limitation. Missing data are rare if instructions are clear; if ≤1 item is missing, mean imputation using the patient's remaining items is acceptable.

3

LEFS total score 0–80: scores >70 indicate near-normal lower-extremity function; 50–70 indicate mild-to-moderate functional limitations suitable for outpatient rehabilitation; 30–50 indicate moderate-to-severe limitations requiring structured therapy or assistive devices; <30 indicate severe limitations requiring intensive intervention or assistive equipment. Minimal clinically important difference (MCID) is approximately 9 points—a change ≥9 points represents meaningful improvement or deterioration clinically. In post-injury rehabilitation, a patient improving from 30 to 39 (9-point gain) is considered to have made meaningful progress. Return-to-work or return-to-sport thresholds vary by activity demands; athletes typically require scores >65–70, while sedentary workers may be satisfied with 50–60.

Common pitfalls

  • Using LEFS immediately after acute lower-extremity injury when pain, swelling, and acute protective guarding dominate; allow 1–2 weeks for acute inflammation to resolve before baseline LEFS.
  • Administering LEFS without considering activity context; a sedentary patient's LEFS score of 50 may be adequate for their lifestyle, while an athlete requires >70. Interpret against patient's activity goals.
  • Expecting LEFS to differentiate between, e.g., pain-driven vs. weakness-driven limitation; LEFS captures overall functional impact but not underlying mechanism. Use supplementary tests (strength, pain scale, ROM) to understand etiology.
  • Failing to administer LEFS consistently across follow-up visits; standardize timing (e.g., always at 2-week intervals) to reduce temporal variability in change scores.

Frequently asked questions

How is LEFS different from condition-specific scales like IKDC (knee) or FAOS (ankle)?

LEFS is generic and applies to any lower-extremity condition; IKDC and FAOS are joint-specific and more detailed. LEFS is faster (20 items) and enables comparison across diagnoses. Use LEFS for overall lower-extremity function tracking; supplement with condition-specific scales for detailed joint-specific outcomes. Best practice: use both LEFS + IKDC in knee patients for comprehensive assessment.

What is the minimal clinically important difference (MCID) on LEFS?

MCID is approximately 9 points on the 0–80 scale. A change ≥9 points represents meaningful clinical change. For example, improving from 35 to 44 (9-point gain) is considered clinically meaningful progress in rehabilitation.

Can LEFS be used in elderly patients with multiple lower-extremity problems (arthritis in knee and ankle)?

Yes. LEFS captures overall lower-extremity function regardless of which joints are affected. In elderly patients with multi-joint osteoarthritis, LEFS provides an integrated view of function; individual joint scales (IKDC, FAOS) can also be used to identify which joints drive the most limitation.

How does LEFS relate to quality of life measures like SF-36?

LEFS measures lower-extremity functional limitation; SF-36 measures overall health and quality of life (physical, mental, social). LEFS is condition-focused and specific; SF-36 is broader. For lower-extremity rehabilitation, LEFS is more sensitive to change than the physical function subscale of SF-36. Consider using LEFS for functional tracking and SF-36 for holistic health impact assessment.

Related methods

Sources

  1. Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. Phys Ther. 1999;79(4):371-383.

    Open DOI reference
    Copied.